Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Acquisition Strategy Differentiates Company in Projected $51B Global Cannabis Market
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) — via IBN — Lucy Scientific Discovery Inc. (NASDAQ:…
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) — via IBN — Lucy Scientific Discovery Inc. (NASDAQ:…
Episode to be Broadcast on Monday, September 11th and Tuesday, September 19th 2023 at 7:30…
WALTHAM, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company…
BOSTON, Sept. 08, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
Aditxt Chairman, Co-Founder, and Chief Executive Officer Amro Albanna will deliver the company presentation on…
Toronto, Ontario–(Newsfile Corp. – September 8, 2023) – Tenet Fintech Group Inc. (CSE: PKK) (OTC…
Vancouver, British Columbia–(Newsfile Corp. – September 8, 2023) – Neptune Digital Assets Corp. (TSXV: NDA)…
Highlights AHI enters collaboration with His Excellency Dr Obaid Alketbi. Bin Farhood Group Founders have…
SINGAPORE, Sep 8, 2023 – (ACN Newswire) – IEXS announced exciting news in September. With…
KUALA LUMPUR, Sep 8, 2023 – (ACN Newswire) – Mercury Securities Group Berhad is pleased…
FREMONT, Calif.–(BUSINESS WIRE)–Seagate HDD Cayman (the “Company”), a subsidiary of Seagate Technology Holdings plc (NASDAQ:…
DENVER–(BUSINESS WIRE)–Advanced Energy Industries, Inc. (Nasdaq: AEIS), a global leader in highly engineered, precision power…
Sale of ninth largest private dealership group in the US includes 29 franchises, six collision…
DENVER & ROME–(BUSINESS WIRE)–Palantir Technologies Inc. (NYSE: PLTR) (“Palantir”) and Gemelli Generator Real World Data…
Pending approval, erdafitinib, an investigational, once-daily oral pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor,1…
Press release – No. 11 / 2023 SAVE THE DATE: Zealand Pharma to host Obesity…
NEW YORK–(BUSINESS WIRE)–#bestplacetowork–Great Place To Work® and Fortune magazine have selected Coro as one of…
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
HONG KONG, Sep 8, 2023 – (ACN Newswire) – According to the latest Hong Kong…
KUALA LUMPUR, Sep 8, 2023 – (ACN Newswire) – Paessler, the IT monitoring expert, has…